A Hepatic Scaffold from Decellularized Liver Tissue: Food for Thought
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Allogeneic liver transplantation is still deemed the gold standard solution for end-stage organ failure; however, donor organ shortages have led to extended waiting lists for organ transplants. In order to overcome the lack of donors, the development of new therapeutic options is mandatory. In the last several years, organ bioengineering has been extensively explored to provide transplantable tissues or whole organs with the final goal of creating a three-dimensional growth microenvironment mimicking the native structure. It has been frequently reported that an extracellular matrix-based scaffold offers a structural support and important biological molecules that could help cellular proliferation during the recellularization process. The aim of the present review is to underline the recent developments in cell-on-scaffold technology for liver bioengineering, taking into account: (1) biological and synthetic scaffolds; (2) animal and human tissue decellularization; (3) scaffold recellularization; (4) 3D bioprinting; and (5) organoid technology. Future possible clinical applications in regenerative medicine for liver tissue engineering and for drug testing were underlined and dissected.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An overview of tissue and whole organ decellularization processes
Crapo, P. M., Gilbert, T. W., & Badylak, S. F. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.057 · Cited by 3,591
The Extracellular Matrix: Not Just Pretty Fibrils
Hynes, R. O. (2009) · Science · doi:10.1126/science.1176009 · Cited by 3,527 · cited 1×
“In fact, these scaffolds are composed of organ-specific ECM that contain growth factors important for cellular proliferation and function [27,28].”
BackgroundDesigning materials for biology and medicine
Langer, R., & Tirrell, D. A. (2004) · Nature · doi:10.1038/nature02388 · Cited by 3,198 · cited 1×
“It has been well established that cells adapt to their surrounding microenvironment through local signals via the activation (or the suppression) of specific pathways concerning cellular proliferation, differentiation, and function [31].”
BackgroundModeling Development and Disease with Organoids
Clevers, H. (2016) · Cell · doi:10.1016/j.cell.2016.05.082 · Cited by 3,196
Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart
Ott, H. C., Matthiesen, T. S., Goh, S.-K., Black, L. D., Kren, S. M., Netoff, T. I., & Taylor, D. A. (2008) · Nature Medicine · doi:10.1038/nm1684 · Cited by 2,650 · cited 2×
“The use of ECM-based scaffolds is becoming more and more attractive in RM and organ engineering strategies due to whole organ decellularization [25,48].”
BackgroundMethodVascularized and functional human liver from an iPSC-derived organ bud transplant
Takebe, T., Sekine, K., Enomura, M., Koike, H., Kimura, M., Ogaeri, T., Zhang, R.-R., Ueno, Y., Zheng, Y.-W., Koike, N., et al. (2013) · Nature · doi:10.1038/nature12271 · Cited by 2,170 · cited 1×
“The use of iPSCs have no ethical problems and do not induce host immune rejection [105].”
BackgroundFrom 3D cell culture to organs-on-chips
Huh, D., Hamilton, G. A., & Ingber, D. E. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.09.005 · Cited by 1,834
Long-Term Culture of Genome-Stable Bipotent Stem Cells from Adult Human Liver
Huch, M., Gehart, H., van Boxtel, R., Hamer, K., Blokzijl, F., Verstegen, M. M. A., Ellis, E., van Wenum, M., Fuchs, S. A., de Ligt, J., et al. (2015) · Cell · doi:10.1016/j.cell.2014.11.050 · Cited by 1,619
Induced pluripotent stem cell technology: a decade of progress.
Shi, Y., Inoue, H., Wu, J. C., & Yamanaka, S. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.245 · Cited by 1,525 · cited 1×
“Currently, there are different protocols for creating iPSCs based on non-integrating genomic modifications, protein introductions, and use of chemical agents [107,108].”
BackgroundUygun, B. E., Soto-Gutierrez, A., Yagi, H., Izamis, M.-L., Guzzardi, M. A., Shulman, C., Milwid, J., Kobayashi, N., Tilles, A., Berthiaume, F., et al. (2010) · Nature Medicine · doi:10.1038/nm.2170 · Cited by 1,370
Role of the extracellular matrix in regulating stem cell fate
Watt, F. M., & Huck, W. T. S. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3620 · Cited by 861
Three-Dimensional Cell Cultures in Drug Discovery and Development
Fang, Y., & Eglen, R. M. (2017) · SLAS Discovery · doi:10.1177/1087057117696795 · Cited by 849
A nonviral minicircle vector for deriving human iPS cells
Jia, F., Wilson, K. D., Sun, N., Gupta, D. M., Huang, M., Li, Z., Panetta, N. J., Chen, Z. Y., Robbins, R. C., Kay, M. A., et al. (2010) · Nature Methods · doi:10.1038/nmeth.1426 · Cited by 734 · cited 1×
“iPSCs present the same level of pluripotency as ESCs and constitute an unlimited cell source that gives rise to both parenchymal and supportive cells [103].”
BackgroundThe use of whole organ decellularization for the generation of a vascularized liver organoid
Baptista, P. M., Siddiqui, M. M., Lozier, G., Rodriguez, S. R., Atala, A., & Soker, S. (2011) · Hepatology · doi:10.1002/hep.24067 · Cited by 681
LeCluyse, E. L. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00135-x · Cited by 477
Bioprinting for vascular and vascularized tissue biofabrication
Datta, P., Ayan, B., & Ozbolat, I. T. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.01.035 · Cited by 431
Decellularized human liver as a natural 3D-scaffold for liver bioengineering and transplantation
Mazza, G., Rombouts, K., Rennie Hall, A., Urbani, L., Vinh Luong, T., Al-Akkad, W., Longato, L., Brown, D., Maghsoudlou, P., Dhillon, A. P., et al. (2015) · Scientific Reports · doi:10.1038/srep13079 · Cited by 415 · cited 3×
“[56] applied decellularization to a whole human liver and successfully obtained a human whole-liver acellular ECM-based scaffold for the first time.”
MethodHuman hepatocyte transplantation: current experience and future challenges
Dhawan, A., Puppi, J., Hughes, R. D., & Mitry, R. R. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.44 · Cited by 362 · cited 1×
“Moreover, the inability of healthcare professionals to monitor graft health and the frequent cases of rejection limit the use of hepatocyte transplantation in clinical practice [6].”
BackgroundA Whole-Organ Regenerative Medicine Approach for Liver Replacement
Soto-Gutierrez, A., Zhang, L., Medberry, C., Fukumitsu, K., Faulk, D., Jiang, H., Reing, J., Gramignoli, R., Komori, J., Ross, M., et al. (2011) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2010.0698 · Cited by 311
Decellularization for whole organ bioengineering
Arenas-Herrera, J. E., Ko, I. K., Atala, A., & Yoo, J. J. (2013) · Biomedical Materials · doi:10.1088/1748-6041/8/1/014106 · Cited by 221
Wang, Y., Cui, C.-B., Yamauchi, M., Miguez, P., Roach, M., Malavarca, R., Costello, J. M., Cardinale, V., Wauthier, E., Barbier, C., et al. (2011) · Hepatology · doi:10.1002/hep.24012 · Cited by 220
Human-Scale Whole-Organ Bioengineering for Liver Transplantation: A Regenerative Medicine Approach
Yagi, H., Fukumitsu, K., Fukuda, K., Kitago, M., Shinoda, M., Obara, H., Itano, O., Kawachi, S., Tanabe, M., Coudriet, G. M., et al. (2013) · Cell Transplantation · doi:10.3727/096368912x654939 · Cited by 188 · cited 2×
“[68] verified that a dualdetergent protocol (SDS and Triton X-100) could be used to acquire a porcine liver acellular scaffold that preserved ultrastructural extracellular matrix elements, functional features of the native microvasculature, and the bile drainage network in addition to important growth factors necessar…”
MethodBioengineered transplantable porcine livers with re-endothelialized vasculature
Ko, I. K., Peng, L., Peloso, A., Smith, C. J., Dhal, A., Deegan, D. B., Zimmerman, C., Clouse, C., Zhao, W., Shupe, T. D., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.11.027 · Cited by 148
Self-citationBao, J., Shi, Y., Sun, H., Yin, X., Yang, R., Li, L., Chen, X., & Bu, H. (2011) · Cell Transplantation · doi:10.3727/096368910x536572 · Cited by 133
Jiang, W.-C., Cheng, Y.-H., Yen, M.-H., Chang, Y., Yang, V. W., & Lee, O. K. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.01.024 · Cited by 117
Differentiation of progenitors in the liver: a matter of local choice
Boulter, L., Lu, W.-Y., & Forbes, S. J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66026 · Cited by 116 · cited 1×
“As previously reported, liver transplantation is still considered the only successful treatment both for chronic end-stage liver disease in addition to acute liver failure [2,3].”
BackgroundImmunogenicity of Decellularized Porcine Liver for Bioengineered Hepatic Tissue
Mirmalek-Sani, S.-H., Sullivan, D. C., Zimmerman, C., Shupe, T. D., & Petersen, B. E. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.05.002 · Cited by 115
Park, K.-M., Hussein, K. H., Hong, S.-H., Ahn, C., Yang, S.-R., Park, S.-M., Kweon, O.-K., Kim, B.-M., & Woo, H.-M. (2016) · Tissue Engineering Part A · doi:10.1089/ten.tea.2015.0313 · Cited by 113
A decade of progress in liver regenerative medicine
Zhang, J., Zhao, X., Liang, L., Li, J., Demirci, U., & Wang, S. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2017.11.027 · Cited by 111 · cited 1×
“BALs could eliminate toxins accumulating in liver failure and supply liver cells supporting the organ with respect to synthetic and regulatory functions [9].”
BackgroundBao, J., Wu, Q., Sun, J., Zhou, Y., Wang, Y., Jiang, X., Li, L., Shi, Y., & Bu, H. (2015) · Scientific Reports · doi:10.1038/srep10756 · Cited by 82
Zhou, P., Huang, Y., Guo, Y., Wang, L., Ling, C., Guo, Q., Wang, Y., Zhu, S., Fan, X., Zhu, M., et al. (2016) · Artificial Organs · doi:10.1111/aor.12645 · Cited by 73
Struecker, B., Butter, A., Hillebrandt, K., Polenz, D., Reutzel-Selke, A., Tang, P., Lippert, S., Leder, A., Rohn, S., Geisel, D., et al. (2017) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.1948 · Cited by 65 · cited 2×
“Uncommonly, two years later, the same group presented a version designed for a small animal model [64].”
BackgroundOgiso, S., Yasuchika, K., Fukumitsu, K., Ishii, T., Kojima, H., Miyauchi, Y., Yamaoka, R., Komori, J., Katayama, H., Kawai, T., et al. (2016) · Scientific Reports · doi:10.1038/srep35887 · Cited by 59
Mesenchymal stem cells support hepatocyte function in engineered liver grafts
Kadota, Y., Yagi, H., Inomata, K., Matsubara, K., Hibi, T., Abe, Y., Kitago, M., Shinoda, M., Obara, H., Itano, O., et al. (2014) · Organogenesis · doi:10.4161/org.27879 · Cited by 58 · cited 1×
“Rat SVC-p Trypsin, Triton X-100 + EGTA Rat hepatocytes + rat BMMSCs PV-i (6) [117]”
BackgroundAgarwal, T., Narayan, R., Maji, S., Ghosh, S. K., & Maiti, T. K. (2018) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2594 · Cited by 46
Gao, M., Wang, Y., He, Y., Li, Y., Wu, Q., Yang, G., Zhou, Y., Wu, D., Bao, J., & Bu, H. (2019) · Xenotransplantation · doi:10.1111/xen.12470 · Cited by 41
Cited by
Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer
Wu, F., Yang, J., Liu, J., Wang, Y., Mu, J., Zeng, Q., Deng, S., & Zhou, H. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00641-0 · Cited by 773
Zhang, X., Chen, X., Hong, H., Hu, R., Liu, J., & Liu, C. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.09.014 · Cited by 680
Massaro, M. S., Pálek, R., Rosendorf, J., Červenková, L., Liška, V., & Moulisová, V. (2021) · Materials Science and Engineering: C · doi:10.1016/j.msec.2021.112203 · Cited by 82
Li, K., Tharwat, M., Larson, E. L., Felgendreff, P., Hosseiniasl, S. M., Rmilah, A. A., Safwat, K., Ross, J. J., & Nyberg, S. L. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.833163 · Cited by 26
Metadata
- Authors
- Croce, S., Peloso, A., Zoro, T., Avanzini, M. A., & Cobianchi, L.
- Venue
- Biomolecules
- Publisher
- MDPI AG
- Published
- 2019-12-02
- Volume
- 9
- Issue
- 12
- Pages
- 813
- ISSN
- 2218-273X (ISSN-L)
- OpenAlex
- W2989618014
- Cited by
- 57
- References
- 36
- FWCI
- 7.56
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.